Express News | Shift in Virus Prevention and Control Concepts Boosts Daan Gene to Limit Up

BreakingsMay 8 09:55

Express News | The avian flu sector in the A-share market surged in the afternoon session, with Zhongsheng Pharmaceutical hitting the daily price limit. Oriental Biotech, Zhijiang Biotech, Hualan Vaccine, Yiling Pharmaceutical, and Tiankang Biotech also rose in tandem.

BreakingsMay 7 13:06

Hualan Biological Vaccine Inc.: First Quarter Report 2026

SZSIApr 27 00:00 · Announcements

Hualan Vaccine (301207.SZ) reported its first-quarter performance, with a net profit attributable to shareholders of 37.37 million yuan, representing a 14.00% increase.

Hualan Vaccine (301207.SZ) released its Q1 2026 report, showing operating revenue of 26.7754 million yuan, representing a year-on-year increase of 10.27%. Net profit attributable to shareholders of the listed company amounted to 37.3657 million yuan, marking a year-on-year growth of 14.00%. Net profit attributable to shareholders of the listed company after excluding non-recurring gains and losses reached 26.1474 million yuan, reflecting a year-on-year surge of 69.61%. Basic earnings per share stood at 0.0628 yuan.

Zhitong FinanceApr 26 16:54

CSC Financial: The phased production of biologics continues to advance, benefiting capacity optimization and efficiency improvement.

The Notice specifies regulatory requirements for the segmented production of biological products, establishing a comprehensive operational guideline. This notice comprises six provisions, offering provincial drug regulatory authorities a complete set of operational guidelines for segmented production licensing and oversight.

Zhitong FinanceApr 10 14:35

Hualan Vaccine (301207): Revenue rebounds with expectations for sustained recovery

The company released its 2025 annual report, achieving revenue of 1.2 billion yuan (+7% yoy), net profit attributable to shareholders of 180 million yuan (-11% yoy), and non-recurring net profit of 130 million yuan (+9% yoy). The results were impacted by influenza outbreaks.

Huatai SecuritiesMar 30 00:00